Japan: Influenza antiviral drug Avigan production ramped up for COVID-19
by Press Release from Outbreak News Today on (#527SH)
Kenji Sukeno, the President of FUJIFILM Corporation announced Wednesday that it has expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co., Ltd. to significantly increase production of its influenza antiviral drug "Avigan(R) Tablet" (generic name: favipiravir) for treating patients with COVID-19. To further boost the supply of Avigan, Fujifilm is allocating additional capacity at its FUJIFILM Wako Pure ["]
The post Japan: Influenza antiviral drug Avigan production ramped up for COVID-19 appeared first on Outbreak News Today.